Page 4 - Cytek Biosciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cytek biosciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cytek Biosciences Today - Breaking & Trending Today

Cytek Biosciences, Inc. (NASDAQ:CTKB) CTO Ming Yan Sells 1,900 Shares of Stock

Cytek Biosciences, Inc. (NASDAQ:CTKB – Get Free Report) CTO Ming Yan sold 1,900 shares of the stock in a transaction that occurred on Tuesday, April 9th. The shares were sold at an average price of $7.00, for a total value of $13,300.00. Following the completion of the sale, the chief technology officer now directly owns […] ....

New Zealand General , New Zealand , Piper Sandler , Ming Yan , Cytek Biosciences , Blackrock Inc , Cytek Biosciences Company Profile , Goldman Sachs Group , Macquarie Group Ltd , Securities Exchange Commission , Wellington Management Group , Cytek Biosciences Inc , Vanguard Group Inc , Get Free Report , Exchange Commission , Street Corp , Management Group , Macquarie Group , Cytek Biosciences Daily , Nasdaq Ctkb , Insider Trading , Nsider Trades ,

Cytek Biosciences, Inc. (NASDAQ:CTKB) CTO Sells $13,300.00 in Stock

Cytek Biosciences, Inc. (NASDAQ:CTKB – Get Free Report) CTO Ming Yan sold 1,900 shares of the stock in a transaction dated Tuesday, April 9th. The shares were sold at an average price of $7.00, for a total transaction of $13,300.00. Following the completion of the sale, the chief technology officer now owns 6,008,502 shares of […] ....

Piper Sandler , Ming Yan , Cytek Biosciences , Life Insurance Co , Goldman Sachs Group , Royal Bank , Ameritas Investment Partners Inc , Pricet Rowe Associates Inc , Cytek Biosciences Inc , Get Free Report , Investment Partners , Cytek Biosciences Daily ,

Cytek Biosciences (NASDAQ:CTKB) Shares Gap Down to $6.91

Shares of Cytek Biosciences, Inc. (NASDAQ:CTKB – Get Free Report) gapped down before the market opened on Wednesday . The stock had previously closed at $6.91, but opened at $6.53. Cytek Biosciences shares last traded at $6.49, with a volume of 35,759 shares. Wall Street Analysts Forecast Growth CTKB has been the subject of a […] ....

New Zealand General , New Zealand , Cytek Biosciences , Piper Sandler , Ming Yan , Cytek Biosciences Company Profile , Securities Exchange Commission , Goldman Sachs Group , Wellington Management Group , Vanguard Group Inc , Macquarie Group Ltd , Blackrock Inc , Cytek Biosciences Inc , Get Free Report , Exchange Commission , Street Corp , Management Group , Macquarie Group , Cytek Biosciences Daily , Nasdaq Ctkb ,